Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy

por Lorenzo, O., Ramírez, E., Picatoste, B., Egido, J., Tuñón, J.
Publicado 2013

Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy

por Lorenzo, O., Picatoste, B., Ares-Carrasco, S., Ramírez, E., Egido, J., Tuñón, J.
Publicado 2011

Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation

por Fuentes-Antrás, J., Ioan, A. M., Tuñón, J., Egido, J., Lorenzo, Ó.
Publicado 2014

Diagnostic approaches for diabetic cardiomyopathy

por Lorenzo-Almorós, A., Tuñón, J., Orejas, M., Cortés, M., Egido, J., Lorenzo, Ó.
Publicado 2017

Updating Experimental Models of Diabetic Cardiomyopathy

por Fuentes-Antrás, J., Picatoste, B., Gómez-Hernández, A., Egido, J., Tuñón, J., Lorenzo, Ó.
Publicado 2015

Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases

por Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., Lorenzo, Ó.
Publicado 2019

Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking

por Ramírez, E., Picatoste, B., González-Bris, A., Oteo, M., Cruz, F., Caro-Vadillo, A., Egido, J., Tuñón, J., Morcillo, M. A., Lorenzo, Ó.
Publicado 2018

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19

por Esteban-Lucia, L, Zambrano Chacon, M A, Venegas Rodriguez, A M, Devesa-Arbiol, A, Gonzalez-Rodriguez, M, Maure-Blesa, L, Avila-Barahona, P, Pello-Lazaro, A M, Gonzalez-Lorenzo, O, Kallmeyer-Mayor, A M, Fernandez-Roblas, R, Villar-Alvarez, F, Tunon, J, Acena Navarro, A, Franco-Pelaez, J A
Publicado 2021